Exhibit 31.1

             CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRESIDENT
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13a-14 AND 15d-14
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PracticeXpert, Inc. (the "Company")
on Form 10-QSB for the period ending March 31, 2005 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Jonathan Doctor,
Chief Executive Officer and President of the Company, certify, pursuant to Rules
13a-14 and 15-d14 of the Securities Exchange Act of 1934 (the "Exchange Act"),
as adopted pursuant to ss.302 of the Sarbanes-Oxley Act of 2002, that: 1. I have
reviewed this Report;

2.    Based on my knowledge, this Report does not contain any untrue statement
      of a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      Report;

3.    Based on my knowledge, the financial statements, and other financial
      information included in this Report, fairly present in all material
      respects the financial condition, results of operations and cash flows of
      the Company, as of, and for, the periods presented in this Report;

4.    I and the other certifying officers of the Company are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and
      have:

      (a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the Company, including any
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this Report is being
      prepared;
      (b) Evaluated the effectiveness of the Company's disclosure controls and
      procedures and presented in this Report our conclusions about the
      effectiveness of the disclosure controls and procedures, as of the end of
      the period covered by this Report based on such evaluation; and
      (c) Disclosed in this Report any change in the Company's internal control
      over financial reporting that occurred during the Company's most recent
      fiscal quarter (the Company's fourth fiscal quarter in the case of an
      annual report) that has materially affected, or is reasonably likely to
      materially affect, the Company's internal control over financial
      reporting; and

5.    I and the other certifying officers have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      Company's auditors and to the audit committee of the Company's board of
      directors (or persons performing the equivalent functions):

      (a) All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the Company's ability to record,
      process, summarize and report financial information; and
      (b) Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the Company's internal control
      over financial reporting.


/s/ Jonathan Doctor
-------------------
Jonathan Doctor,
Chief Executive Officer and President
May 23, 2005